Despite this, in both RA and SpA TNF plays a prominent role in driving disease, and synovial macrophage numbers and cytokine products are closely associated with disease activity and patient responses to treatment, indicating contributions to inflammation and joint destruction independent of M1/M2 phenotype [20], [39]–[41]. This evidence concerns the gene TNF and rheumatoid arthritis.